Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lara Goldstein

Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report

Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ:ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility agreement for up to $175 million provided by Hercules Capital Inc. (NYSE:HTGC).

The company expects the new non-dilutive financing facility, together with the total existing cash in hand, will provide cash runway until 2025, as the flexible draw availability provides options to optimize liquidity and capital structure moving forward in ATAI’s developments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.